This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Pulmonary Diseases, Other  • Surgical Oncology  • Thoracic Surgery  • Lung Cancer  • Alert me on articles by topic

M. Margaret Kemeny, MD

Arch Surg. 2007;142(1):76.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Surgical oncology in the 20th century centered on the resection of primary cancers and local recurrences. In the 21st century, that tradition may well change to center on the resection of metastatic disease. Metastasis from STS to the lungs has been one of the main sites of disease for this new direction. Much information has been gathered over the last few decades to delineate the appropriate patients with metastatic disease who would benefit from resection. For patients to benefit, the procedures must have acceptable morbidity and mortality and long-term survival must show improvement over other methods. The effect on long-term survival of resection of metastatic disease has not been studied in a randomized fashion. Information has been gathered from several large retrospective studies.

A large study from Memorial Sloan-Kettering Cancer Center was published in the late 1990s that reviewed their experience in treating 719 patients with . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

Benefit of Surgical Treatment of Lung Metastasis in Soft Tissue Sarcoma
Alexander Rehders, Stefan B. Hosch, Peter Scheunemann, Nikolas H. Stoecklein, Wolfram T. Knoefel, and Matthias Peiper
Arch Surg. 2007;142(1):70-75.
ABSTRACT | FULL TEXT